Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Tsu, H.; Chen, X.; Chen, C.T.; Lee, S.J.; Chang, C.N.; Kao, K.H.; Coumar, M.S.; Yeh, Y.T.; Chien, C.H.; Wang, H.S.; Lin, K.T.; Chang, Y.Y.; Wu, S.H.; Chen, Y.S.; Lu, I.L.; Wu, S.Y.; Tsai, T.Y.; Chen, W.C.; Hsieh, H.P.; Chao, Y.S.; Jiaang, W.T.
    2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV (2006), J. Med. Chem., 49, 373-380.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxoethylamino]-1-oxopropyl]-4-[benzothiazol-2-yl]piperazine
-
Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Synonyms

Synonyms Comment Organism
DPP-IV
-
Homo sapiens

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.000527
-
-
Homo sapiens 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxoethylamino]-1-oxopropyl]-4-[benzothiazol-2-yl]piperazine